Kestra Medical adds Conor Hanley to board; amends executive employment agreements

KESTRA MEDICAL TECHNOLOGIES, LTD.

Conor Hanley, CEO of FIRE1, elected to Kestra board effective June 4, 2025, as Class I independent director.
Hanley previously held senior roles at ResMed and co-founded BiancaMed.
Employment agreements for CEO Brian Webster, CFO Vaseem Mahboob, and GC Traci Umberger amended.
Amendments redefine 'Good Reason' for termination, adding title demotion, relocation, compensation cuts, and change in control triggers.
No committee assignments for Hanley; standard non-employee director compensation.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Conor Hanley

Director

KMTS · KESTRA MEDICAL TECHNOLOGIES, LTD.

Effective: 2025-06-04
Filed: June 6, 2025, 7:59 PM ET

On June 4, 2025, the Board of Directors (the “Board”) of Kestra Medical Technologies, Ltd. (the “Company”) elected Mr. Conor Hanley as a new member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Conor Hanley was elected as Director at KESTRA MEDICAL TECHNOLOGIES, LTD..

Action: elected
Role: Director

Exact text from the filing

On June 4, 2025, the Board of Directors (the “Board”) of Kestra Medical Technologies, Ltd. (the “Company”) elected Mr. Conor Hanley as a new member of the Board.

View on SEC.gov

KESTRA MEDICAL TECHNOLOGIES, LTD. filing history →

Source: SEC EDGAR

accession 0001193125-25-136269

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.